Articles from Botanical Solution Inc.

Eddie Gray, veteran pharmaceutical and vaccine industry executive, has joined the Board of Directors of Botanical Solution Inc. (BSI). Mr. Gray is the former President of GlaxoSmithKline Europe, former CEO Dynavax Technologies Corp. and former Chair of the UK Government’s Covid-19 Antivirals Task Force. Eddie earned his B.Sc. (Honors) in Chemistry and Management Studies from the University of London, and completed his MBA at the Cranfield School of Management, England.

Botanical Solution, a leading producer of advanced botanical materials, has won two awards in the 2024 Pharmaceutical Technology Excellence Awards in the Innovation and Business Expansion categories for advancing healthcare through eco-conscious practices and pioneering research and development (R&D).

Today, Botanical Solution Inc. (BSI) announced it has closed another $7.6 million financing, as part of Series A, that will fund the commencement of in-house production of QS-21, pharmaceutical grade vaccine adjuvant. Using cost-effective and scalable proprietary methods, BSI will expand QS-21 use in broader vaccine applications.

Botanical Solution Inc. (BSI) has been named winner of the 2023 Sustainable Product/Service of the Year Award from the UK’s Big Sustainability Awards.

Botanical Solution Inc. (BSI), has been named winner of the 2023 Best Process Innovation Award from ICIS Chemical Business.

Botanical Solution Inc. (BSI), the multiple award-winning innovator of sustainable, highly consistent and cost effective Advanced Botanical Materials, has successfully secured an additional $7 million investment.

Harvard University has invited Botanical Solution Inc. (BSI) CEO Gaston Salinas, (BSI), to speak at its upcoming seminar on Global Health, Biodiversity and Therapeutics, to be held Friday, June 9, 2023. Mr. Salinas will present, “Exploiting the plant Quillaja saponaria as a source of therapeutic compounds – discovery and industrial production”.

Croda Pharma and BSI announced that they have entered into a strategic collaboration agreement to support the sustainable sourcing of pharmaceutical grade adjuvant QS-21, a potent component of adjuvant systems.

Botanical Solution Inc. (BSI), innovator of sustainable, consistent and cost-effective Advanced Botanical Materials (ABM) for agricultural and pharmaceutical applications, has entered into a Partnership Agreement with Croda Pharma to build a robust, scalable and truly sustainable supply chain and deliver kilogram-quantities of QS-21 to the pharmaceutical industry.

Botanical Solution Inc. (BSI), innovator of sustainable, consistent and cost-effective Advanced Botanical Materials for agricultural and pharmaceutical applications, has won the Crop Science Award for “Best New Biological Product (Biopesticide)”.

Botanical Solution Inc. (BSI), innovator of sustainable, consistent and cost-effective Advanced Botanical Materials for agricultural and pharmaceutical applications, has been named a ‘Finalist’ in the Crop Science Award for “Best Industry Collaboration with distribution partner Syngenta.”

Botanical Solution Inc. (BSI), innovator of sustainable, consistent and cost-effective Advanced Botanical Materials (ABM) for agricultural and pharmaceutical applications, has won the “Best Biotech Startup Business of the Year 2022” Award from the World BioProtection Forum and was selected finalist for two more categories. This Award was presented to BSI Senior Vice President Latin America Diego Ibañez who also was one of the distinguished speakers at the main event, held on May 23 in Birmingham, UK.

Botanical Solution Inc. (BSI), innovator of sustainable, consistent and cost-effective Advanced Botanical Materials for agricultural and pharmaceutical applications, has successfully closed $6.1 million in a Series A round led by Palo Alto based VC Firm, Otter Capital. This round of funding will enhance BSI’s value proposition by facilitating the geographic expansion of its current botanical-based products and development of a new product pipeline derived from its proprietary biotech platform.